Have A Question?

Connect with Camargo today.

Contact Us
Blog & Resources Webinars The Value of Real World Data in Orphan and 505(b)(2) Drug Development

The Value of Real World Data in Orphan and 505(b)(2) Drug Development

Date: October 9th, 2019

Presented by: Ken Phelps, president and co-founder, Camargo


In orphan drug development, smaller patient populations present unique challenges when it comes to demonstrating safety and efficacy to support regulatory approval. Similarly, 505(b)(2) drug development by definition utilizes publicly available data sources to support approval.

In this webinar, we'll share insights to harness the strategic value of real world data to build optimized drug development programs that minimize the time and cost of sponsor-driven studies.

Get Our Diverse Expertise Working for You

To learn how you can benefit from our regulatory and strategic development expertise, view our Solutions or Contact Us.

Camargo Pharmaceutical Services provides comprehensive drug development solutions, specializing in customized programs including the 505(b)(2) pathway.

9825 Kenwood Road
Suite 203
Cincinnati OH, 45242
Durham Office
800 Taylor Street
Suite 101
Durham NC, 27701
Montreal Office
507 Place d'Armes
Suite 1101
Montreal, QC H2Y 2W8, Canada
Phone 513.561.3329
Toll Free 888.451.5708
Subscribe for our Latest Insights